Avidicure

Multifunctional antibodies to modulate the immune system

Biotechnology Research · South Holland

About

At Avidicure, we discover and develop entirely new antibody therapies, called “Actibodies”. Our first-in-class product platform is designed to deliver targeted and potent immune-modulating treatments for patients with cancer or auto-immune diseases.

Details

  • Website: https://avidicure.com/
  • Founded: 2022
  • Company Size: 29 employees
  • Headquarters: Leiden, South Holland